Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.870
+0.010 (0.54%)
At close: Dec 27, 2024, 4:00 PM
1.910
+0.040 (2.13%)
After-hours: Dec 27, 2024, 7:50 PM EST
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 122 employees as of December 31, 2023. The number of employees decreased by 62 or -33.70% compared to the previous year.
Employees
122
Change (1Y)
-62
Growth (1Y)
-33.70%
Revenue / Employee
$1,667
Profits / Employee
-$925,214
Market Cap
48.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
SHL Telemedicine | 583 |
Singular Genomics Systems | 255 |
Achilles Therapeutics | 215 |
Celularity | 120 |
Xilio Therapeutics | 73 |
iCAD, Inc. | 69 |
Kezar Life Sciences | 58 |
MAIA Biotechnology | 13 |
INO News
- 14 days ago - Gold Down Over 1%; Inovio Pharmaceuticals Shares Plummet - Benzinga
- 14 days ago - INOVIO Announces Pricing of $30 Million Public Offering - PRNewsWire
- 15 days ago - INOVIO Announces Proposed Public Offering - PRNewsWire
- 24 days ago - New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial - PRNewsWire
- 4 weeks ago - INOVIO Reports Inducement Grant Under Inducement Plan - PRNewsWire
- 6 weeks ago - European And US Vaccine Stocks Are Under Pressure - Here's WHy - Benzinga
- 6 weeks ago - Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights - PRNewsWire